Article
Inhibin β-A (INHBA) induces epithelial–mesenchymal transition and accelerates the motility of breast cancer cells by activating the TGF-β signaling pathway
1 Jan 2021
Abstract excerpt
Accumulating evidence indicates that INHBA (Inhibin β-A, a member of the TGF-β superfamily) functions as an oncogene in cancer progression. However, little is known as to how INHBA regulates the progression and aggressiveness of breast cancer (BC). This study explored the function and underlying mechanism of INHBA in epithelial–mesenchymal transition (EMT) of BC cells. INHBA expression in BC cell lines was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
